Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine delivery systems.

Saul Shiffman1, Reginald V Fant, August R Buchhalter

  • 1University of Pittsburgh Smoking Research Group, Department of Psychology, Pittsburgh, PA, USA. shiffman@pinneyassociates.com

Expert Opinion on Drug Delivery
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitragynine and 7-hydroxy-mitragyine plasma pharmacokinetics in humans after single and 15 multiple oral kratom extract doses.

Journal of analytical toxicology·2026
Same author

Behavioral pharmacology study to inform the switching potential and abuse liability of tobacco-flavored and menthol-flavored pod-based electronic nicotine delivery systems with 5% nicotine concentration.

Experimental and clinical psychopharmacology·2026
Same author

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.

Journal of psychopharmacology (Oxford, England)·2026
Same author

US adults' complete switching away from cigarettes by menthol- and tobacco-flavored ENDS and by menthol cigarette preference: testing robustness to missing data.

Internal and emergency medicine·2026
Same author

Safety and Tolerability of Single and Multiple Daily Oral Doses of Dried Kratom Leaf Powder in a Randomized Trial in Healthy Volunteers.

Therapeutic drug monitoring·2026
Same journal

Dry powder inhaler selection in COPD: integrating device design, formulation performance, and patient inspiratory capability.

Expert opinion on drug delivery·2026
Same journal

Letter to the Editor: 'saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Response to letter to the editor: 'Saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Mechanism-guided metal complex therapeutics for biofilm-driven wound infections and transdermal delivery.

Expert opinion on drug delivery·2026
Same journal

Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies.

Expert opinion on drug delivery·2026
Same journal

Drug penetration in solid tumors: influence of drug size and capillary architecture.

Expert opinion on drug delivery·2026
See all related articles

Medicinal nicotine products have aided smoking cessation for two decades. New nicotine delivery systems and applications show promise for improving quit rates and managing nicotine dependence.

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Public Health

Background:

  • Medicinal nicotine has been a cornerstone of smoking cessation efforts for 20 years.
  • Available products include patches, gum, lozenges, nasal spray, inhalers, and sublingual tablets.

Purpose of the Study:

  • To review current medicinal nicotine products, their pharmacokinetics, and dosing.
  • To explore novel nicotine delivery systems and potential new applications.

Main Methods:

  • Literature review of existing and emerging medicinal nicotine products.
  • Analysis of pharmacokinetic data and dosing recommendations.
  • Exploration of new product development and therapeutic applications.

Main Results:

Related Experiment Videos

  • Established nicotine products have significantly increased successful quit rates.
  • Emerging products include high-dose patches, rapid-release gum, and novel delivery methods like drinks and inhalers.
  • Potential new uses encompass relapse prevention, nicotine maintenance, and gradual quitting strategies.

Conclusions:

  • Medicinal nicotine is effective for smoking cessation.
  • Innovations in nicotine delivery and application offer enhanced strategies for tobacco harm reduction and dependence management.